These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Potential life-threatening events in schools involving rescue inhalers, epinephrine autoinjectors, and glucagon delivery devices: reports from school nurses. Allen K, Henselman K, Laird B, Quiñones A, Reutzel T. J Sch Nurs; 2012 Feb; 28(1):47-55. PubMed ID: 21878573 [Abstract] [Full Text] [Related]
11. The Need for Required Stock Epinephrine in All Schools: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. Russell AF, Bingemann TA, Cooke AT, Ponda P, Pistiner M, Jean T, Nanda A, Jobrack J, Hoyt AEW, Young MC. J Allergy Clin Immunol Pract; 2023 Apr; 11(4):1068-1082.e1. PubMed ID: 36716997 [Abstract] [Full Text] [Related]
18. Training and administration of epinephrine auto-injectors for anaphylaxis treatment in US schools: results from the EpiPen4Schools(®) pilot survey. Hogue SL, Goss D, Hollis K, Silvia S, White MV. J Asthma Allergy; 2016 Apr; 9():109-15. PubMed ID: 27382317 [Abstract] [Full Text] [Related]
19. Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis. Shaker MS, Greenhawt MJ. JAMA Pediatr; 2019 Feb 01; 173(2):169-175. PubMed ID: 30575857 [Abstract] [Full Text] [Related]
20. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community. Simons FE, World Allergy Organization. Ann Allergy Asthma Immunol; 2009 May 01; 102(5):403-9. PubMed ID: 19492662 [Abstract] [Full Text] [Related] Page: [Next] [New Search]